期刊文献+

直肠神经内分泌肿瘤超声内镜临床特点研究 被引量:1

Clinical Characteristics of Endoscopic Ultrasonography in Rectal Neuroendocrine Tumors
下载PDF
导出
摘要 神经内分泌肿瘤的生物学特性呈多样化表现,其存在恶变可能,胃肠部位为发生神经内分泌肿瘤的常见位置。在一般情况下,该疾病通常于结肠镜检查中可以发现。病灶很少发生转移,其为一类较为典型的局部、小规格且无功能的肿瘤类型。和以往相比,当前我国医学基础有所进展,在这种情况下,超声内镜检查也得以普及,致使疾病的检出率有所上升,并且内镜下微创治疗的成效也受到了认可。特此,本文全面分析直肠神经内分泌肿瘤超声内镜临床特点,旨意为相关人员的研究工作提供参考文献。 The biological characteristics of neuroendocrine tumors are diversified,and there is the possibility of malignant change.The gastrointestinal tract is a common site for neuroendocrine tumors.In general,the disease is usually detected by colonoscopy.The lesions rarely metastasize,which is a typical local,small and nonfunctional tumor type.Compared with the past,the medical foundation of China has made some progress,in this case,endoscopic ultrasonography has been popularized.As a result,the detection rate of the disease has increased.Moreover,the effectiveness of minimally invasive endoscopic treatment has been recognized.In this paper,the clinical characteristics of endoscopic ultrasonography of rectal neuroendocrine tumors were comprehensively analyzed.The purpose is to provide references for the research work of related personnel.
作者 官川博 张毅宏 GUAN Chuan-bo;ZHANG Yi-hong(Department of Gastroenterology,Tianjin Beichen Hospital,Tianjin 300400)
出处 《中国医疗器械信息》 2020年第18期37-38,共2页 China Medical Device Information
关键词 直肠神经内分泌肿瘤 超声内镜 临床特点 rectal neuroendocrine tumor endoscopic ultrasonography clinical characteristics
  • 相关文献

参考文献7

二级参考文献48

  • 1蒋建霞,施瑞华,林琳.消化系神经内分泌癌及文献分析209例[J].世界华人消化杂志,2007,15(4):421-426. 被引量:34
  • 2Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classificationof tumours of the digestive system. 4th ed. Lyon: InternationalAgency for Research on Cancer, 2010.
  • 3Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE,Abdalla EK, Fleming JB, Vauthey JN, Rashid A, Evans DB. Onehundred years after "carcinoid": epidemiology of and prognosticfactors for neuroendocrine tumors in 35,825 cases in the UnitedStates. J Clin Oncol 2008; 26: 3063-3072 [PMID: 18565894 DOI:10.1200/jco.2007.15.4377].
  • 4National Comprehensive Cancer Network. NCCN clinical practiceguidelines in oncology: Neuroendocrine tumors. 2011. Availablefrom: URL: http://www.nccn.org/.
  • 5Kulke MH, Anthony LB, Bushnell DL, de Herder WW, GoldsmithSJ, Klimstra DS, Marx SJ, Pasieka JL, Pommier RF, Yao JC, JensenRT. NANETS treatment guidelines: well-differentiated neuroendocrinetumors of the stomach and pancreas. Pancreas 2010; 39: 735-752[PMID: 20664472 DOI: 10.1097/MPA.0b013e3181ebb168].
  • 6Steinmüller T, Kianmanesh R, Falconi M, Scarpa A, Taal B,Kwekkeboom DJ, Lopes JM, Perren A, Nikou G, Yao J, DelleFave GF, O'Toole D. Consensus guidelines for the managementof patients with liver metastases from digestive (neuro)endocrinetumors: foregut, midgut, hindgut, and unknown primary.Neuroendocrinology 2008; 87: 47-62 [PMID: 18097131 DOI:10.1159/000111037].
  • 7Madeira I, Terris B, Voss M, Denys A, Sauvanet A, Flejou JF,Vilgrain V, Belghiti J, Bernades P, Ruszniewski P. Prognosticfactors in patients with endocrine tumours of the duodenopancreaticarea. Gut 1998; 43: 422-427 [PMID: 9863490].
  • 8Mignon M. Natural history of neuroendocrine enteropancreatictumors. Digestion 2000; 62 Suppl 1: 51-58 [PMID: 10940688].
  • 9Touzios JG, Kiely JM, Pitt SC, Rilling WS, Quebbeman EJ,Wilson SD, Pitt HA. Neuroendocrine hepatic metastases: doesaggressive management improve survival- Ann Surg 2005; 241:776-783; discussion 783-785 [PMID: 15849513].
  • 10Zerbi A, Falconi M, Rindi G, Delle Fave G, Tomassetti P, PasqualiC, Capitanio V, Boninsegna L, Di Carlo V. Clinicopathologicalfeatures of pancreatic endocrine tumors: a prospective multicenterstudy in Italy of 297 sporadic cases. Am J Gastroenterol 2010; 105:1421-1429 [PMID: 20087335 DOI: 10.1038/ajg.2009.747].

共引文献31

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部